UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000014481 |
|---|---|
| Receipt number | R000016778 |
| Scientific Title | The novel therapeutic cancer peptide vaccine therapy for patients with locally advanced or metastatic pacreatic cancer combined with Gemcitabine as the first line therapy.-Phase I/II study- |
| Date of disclosure of the study information | 2014/08/01 |
| Last modified on | 2023/01/10 09:32:01 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2014/07/04 21:23:02 | ||
| 2 | Update | 2017/04/27 18:58:29 | Name of primary person or sponsor Organization |
|
| 3 | Update | 2017/04/27 18:59:38 | Recruitment status |
|
| 4 | Update | 2023/01/10 09:29:25 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 5 | Update | 2023/01/10 09:30:31 | Number of participants that the trial has enrolled |
|
| 6 | Update | 2023/01/10 09:32:01 | Recruitment status Date of IRB Last follow-up date |
